- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01918540
Importance of Hollow or Solid Centralizer for Polished, Collarless and Tapered Stems in Total Hip Arthroplasty
November 25, 2014 updated by: Region Skane
Comparing Hollow and Solid Centralizer Designs When Using a Polished, Collarless, Tapered Hip Prosthesis Stem (MS30). A Prospective, Randomized, Multicenter Study Evaluated by RadioStereometric Analysis (RSA).
The study aims at comparing the effect of hollow or solid centralizer designs on the long time fixation behaviour of hip prosthesis stems that are polished, tapered and collarless.
In a prospective, controlled and randomized study comprising two groups of 30 patients/hips each, the patients will be followed up by RadioStereometric Analysis (RSA) for ten years.
In completion general health questionnaires as well as hip specific scoring instruments will be used to evaluate patient satisfaction and outcome.The hypothesis of the study is that the different centralizers will result in different migration patterns of the stems, which might affect the risk for late aseptic loosening.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Skåne
-
Lund, Skåne, Sweden, 221 85
- Department of Orthopedics, Skåne University Hospital, Lund University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Primary osteoarthritis of the hip necessitating primary hip replacement
- Charnley classification group A and B
- Age 60 - 85 years old at the inclusion time of the study.
Exclusion Criteria:
- Secondary osteoarthritis
- Rheumatoid arthritis
- Malignant disease
- Severe osteoporosis
- Earlier fracture or operation in the hip to be operated on
- Peroperative fracture
- Ongoing corticosteroid (oral) or immunosuppressive medication
- Personal disorders (dementia, alcohol or drug abuse etc) suspected of making completion of the trial uncertain.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Hollow Centralizer
The stem used (MS30)was originally designed with a solid centralizer but has been redesigned to be used with a hollow centralizer.
|
The stem used (MS30)was originally designed with a solid centralizer but has been redesigned to be used with a hollow centralizer.
The patients are randomized to either solid or hollow centralizer
This is the stem used in the study.
|
Active Comparator: Solid Centralizer
The stem used (MS30)was originally designed with a solid centralizer but has been redesigned to be used with a hollow centralizer.
|
This is the stem used in the study.
The stem used (MS30)was originally designed with a solid centralizer but has been redesigned to be used with a hollow centralizer.
The patients are randomized to either solid or hollow centralizer
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Radiostereometric Analysis (RSA)
Time Frame: The first postoperative day, 6 months, 1, 2, 5 and 10 years
|
This will measure the change in stem migration over time and be indicative of long term result.
|
The first postoperative day, 6 months, 1, 2, 5 and 10 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
x-ray
Time Frame: The first postoperative day, 6 months, 1, 2, 5 and 10 years
|
On standard x-rays the progress of radiolucent lines or other signs of loosening will be measured
|
The first postoperative day, 6 months, 1, 2, 5 and 10 years
|
Hip specific questionnaire
Time Frame: Preoperatively, 1, 2, 5 and 10 years
|
Hip disability and Osteoarthritis Score (HOOS) - this is a hip specific questionnaire that will measure how the operation has affected the patients hip function and pain situation
|
Preoperatively, 1, 2, 5 and 10 years
|
General health questionnaire
Time Frame: Preoperatively, 1, 2, 5 and 10 years
|
EuroQol (EQ-5D) - a standardized instrument for use as measure of general health outcome
|
Preoperatively, 1, 2, 5 and 10 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2003
Primary Completion (Actual)
February 1, 2004
Study Completion (Actual)
November 1, 2014
Study Registration Dates
First Submitted
July 4, 2013
First Submitted That Met QC Criteria
August 5, 2013
First Posted (Estimate)
August 7, 2013
Study Record Updates
Last Update Posted (Estimate)
November 26, 2014
Last Update Submitted That Met QC Criteria
November 25, 2014
Last Verified
November 1, 2014
More Information
Terms related to this study
Other Study ID Numbers
- Centralizer study
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Total Hip Arthroplasty
-
DePuy OrthopaedicsJohnson & Johnson Health and Wellness Solutions, Inc.TerminatedTotal Knee Arthroplasty; Total Hip ArthroplastyUnited States
-
DePuy OrthopaedicsJohnson & Johnson Health and Wellness Solutions, Inc.TerminatedTotal Knee Arthroplasty; Total Hip ArthroplastyUnited States
-
National Taiwan University HospitalUnknownTotal Hip Replacement | Total Hip ArthroplastyTaiwan
-
Northern Orthopaedic Division, DenmarkCompletedTotal Knee Arthroplasty | Total Hip ArthroplastyDenmark
-
Ortho Development CorporationOregon Health and Science UniversityEnrolling by invitationTotal Hip Replacement | Total Hip ArthroplastyUnited States
-
James A. KeeneyRecruitingPrimary Total Hip Arthroplasty | Primary Total Knee ArthroplastyUnited States
-
Musgrave Park HospitalBelfast Health and Social Care Trust; Queen's University, Belfast; Belfast Arthroplasty...CompletedTotal Hip Replacement | Total Hip Arthroplasty | THA | THRUnited Kingdom
-
Permedica spaNot yet recruitingTotal Hip ArthroplastyItaly
-
ExactechNot yet recruitingHip Arthroplasty, Total
-
Mauro CrestaniRecruitingTotal Hip ArthroplastyItaly
Clinical Trials on Hollow Centralizer
-
Baxter Healthcare CorporationRecruitingAcute Kidney Failure | Chronic Kidney FailureChina
-
Chinese PLA General HospitalCompleted
-
Axogen CorporationTerminatedTraumatic Nerve InjuryUnited States
-
Boston Scientific CorporationCompletedParoxysmal Atrial Fibrillation (PAF)United States, Spain, Germany, Australia, United Kingdom, Sweden, Czechia, France, Portugal
-
M.D. Anderson Cancer CenterMirati TherapeuticsRecruitingColorectal Cancer | Colon CancerUnited States
-
Second Affiliated Hospital, School of Medicine,...RecruitingKeratitis, Ulcerative | Antibiotic Resistance, Microbial | Photothermal TherapyChina